## AFL: AFLAC Incorporated - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.93 indicates fundamental undervaluation. Quality metrics strong (ROE 16%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($104.74)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Aflac EVP beaver sells $377k in stock after option exercise**
- Source: Investing.com | 20251209T152046 | Somewhat-Bullish | Relevance: 99%
- Steven Kent Beaver, EVP and CFO of Aflac Japan (NYSE:AFL), sold 3,452 shares of Aflac common stock for $377,165 on December 5, 2025, after exercising options for the same number of shares. Following the transaction, Beaver directly owns 43,860 shares. This news follows Aflac's strong Q3 2025 earnings and a declared dividend increase for Q1 2026.

**2. Amundi Sells 61,674 Shares of Aflac Incorporated $AFL**
- Source: MarketBeat | 20251207T081914 | Somewhat-Bullish | Relevance: 99%
-  Amundi reduced its stake in Aflac Incorporated by 2.5% during the second quarter, selling 61,674 shares and now owning 2,370,329 shares valued at $246.44 million. Other institutional investors also adjusted their positions in AFL. Aflac's stock performance, financials, recent earnings, dividend increase, and analyst ratings are detailed, with insiders also actively selling shares recently.

**3. Aflac Inc - Amended Statement of Ownership (SC 13G/A)**
- Source: ADVFN | 20251209T100738 | Neutral | Relevance: 99%
-  This amended Schedule 13G/A filing for Aflac Incorporated details FMR LLC's and Edward C. Johnson 3d's beneficial ownership of Aflac common stock as of December 31, 2007. It indicates FMR LLC beneficially owns 1.931% of the class, and clarifies that the reporting persons are no longer beneficial owners of more than five percent of the outstanding shares, thus ceasing their reporting obligation under Section 13(d). The document also outlines the ownership structures and voting power within FMR LLC and its subsidiaries.

**4. Aflac EVP beaver sells $377k in stock after option exercise**
- Source: Investing.com UK | 20251209T143738 | Somewhat-Bullish | Relevance: 98%
- Aflac's Executive Vice President and CFO of Aflac Japan, Steven Kent Beaver, sold 3,452 shares of common stock for over $377,000 after exercising options. This transaction follows strong third-quarter earnings for Aflac in 2025, with EPS surpassing estimates and revenue exceeding expectations. Other recent developments include a dividend increase and a new partnership with Ameriflex.

**5. Aflac EVP beaver sells $377k in stock after option exercise**
- Source: Investing.com India | 20251209T150910 | Bullish | Relevance: 98%
-  Steven Kent Beaver, EVP and CFO of Aflac Japan, sold 3,452 shares of Aflac common stock worth $377,165 on December 5, 2025, after exercising options for the same number of shares. Following this transaction, Beaver directly holds 43,860 shares. This comes amidst strong third-quarter earnings for Aflac, where the company surpassed revenue and EPS expectations and announced a dividend increase.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $118 | $113 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.09M) |
| Sells | 8 ($2.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Japan Post Holdings : 10.0% (0.0%)
- Vanguard Group Inc: 9.6% (-0.8%)
- Blackrock Inc.: 7.4% (+0.1%)
- State Street Corpora: 4.6% (+0.1%)
- Wells Fargo & Compan: 2.1% (-24.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Quality metrics strong (margin 24%). Balance sheet: strong liquidity (48.2x). Insider selling cluster ($2.5M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $57.8B |
| Beta | 0.66 |
| 52W Range | $96.95 - $115.84 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 14.6 |
| Current P/E | 14.3 |
| YoY Growth | -2.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at -4.6% (minimal 5-day change). Below STRENGTH zone by 8.6pp (needs >4.0% for momentum thesis). Underperforming sector by 3.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.59% (CS: 20) | Weak |
| RSI_14 | 39.7 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.980x | Below |
| vs SMA200 | 1.012x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $108.02
- **Stop Loss:** $104.74 (3.0% risk)
- **Target:** $114.58 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 152
- **Position Value:** $16,419.04
- **Portfolio %:** 16.42%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $2.49 | +40.2% |
| 2025Q2 | $1.71 | $1.78 | +4.3% |
| 2025Q1 | $1.67 | $1.66 | -0.8% |
| 2024Q4 | $1.62 | $1.56 | -3.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*